TerminatedNCT04836377

A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02

Studying Gaucher disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
AVROBIO
Principal Investigator
Milena Veselinovic, MD
AVROBIO
Intervention
Safety and efficacy assessments(other)
Enrollment
4 enrolled
Eligibility
18-99 years · All sexes
Timeline
2021 – 2023

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04836377 on ClinicalTrials.gov

Other trials for Gaucher disease

Additional recruiting or active studies for the same condition.

See all trials for Gaucher disease →

← Back to all trials